Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China
- 1 February 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (2), 763-765
- https://doi.org/10.1128/aac.01053-06
Abstract
A carbapenem-resistant isolate of Klebsiella pneumoniae producing class A carbapenemase KPC-2 was identified in Zhejiang, China. The KPC-2 gene was located on an approximately 60-kb plasmid in a genetic environment partially different from that of blaKPC-2 in the isolates from the United States and Colombia.Keywords
This publication has 16 references indexed in Scilit:
- Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in IsraelAntimicrobial Agents and Chemotherapy, 2006
- First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South AmericaAntimicrobial Agents and Chemotherapy, 2006
- The Spread ofKlebsiella pneumoniaeCarbapenemase–ProducingK. pneumoniaeto Upstate New YorkClinical Infectious Diseases, 2006
- First Isolation of bla IMI-2 in an Enterobacter cloacae Clinical Isolate from ChinaAntimicrobial Agents and Chemotherapy, 2006
- Outbreaks in Distinct Regions Due to a Single Klebsiella pneumoniae Clone Carrying a bla VIM-1 Metallo-β-Lactamase GeneJournal of Clinical Microbiology, 2005
- Nosocomial spread of multi-resistant Klebsiella pneumoniae containing a plasmid encoding multiple β-lactamasesJournal of Medical Microbiology, 2005
- Imipenem Resistance in a Salmonella Clinical Strain Due to Plasmid-Mediated Class A Carbapenemase KPC-2Antimicrobial Agents and Chemotherapy, 2003
- Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolatesJournal of Antimicrobial Chemotherapy, 2003
- Emerging carbapenemases in Gram-negative aerobesClinical Microbiology & Infection, 2002
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001